This datum is confirmed by the observation that the association between BMI and reduced DFS is not found in patients diagnosed with triple-negative breast cancer that, therefore, are not subject to anti-hormone treatment due to a lack of ER/PR expression, and not even in colorectal cancer patients. The gene discussed is ESR1; the disease is triple-negative breast carcinoma.